kabutan

Pharma Foods, 41% Decrease in Ordinary Profit for The Current Fiscal Year

Thu Sep 11, 2025 1:30 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE Prime] announced its financial results in the afternoon session on September 11th (13:30). The consolidated ordinary profit for the fiscal year ended July 2025 decreased by 51.4% from the previous period to 2.55 billion yen. For the fiscal year ending July 2026, the consolidated ordinary profit is expected to drop by 41.2% from the previous period to 1.50 billion yen.

In the most recent three-month period, from May to July (4Q), the consolidated ordinary profit increased 37.4% from the same period last year, reaching 2.78 billion yen. The operating profit margin rose from 12.3% in the same period last year to 14.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2023 68,572 3,610 3,540 3,081 106.7 22 Sep 11, 2023 J-GAAP
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Jul, 2025 65,260 2,367 2,553 368 12.8 25 Sep 11, 2025 J-GAAP
YoY +5.0% -53.7% -51.4% -88.5% -88.6%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2025 Guidance 65,200 2,300 2,500 350 12.2 25 Sep 8, 2025 J-GAAP
Jul, 2025 Results 65,260 2,367 2,553 368 12.8 25 Sep 11, 2025 J-GAAP
Revision Rate +0.1% +2.9% +2.1% +5.1% +5.4%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug - Jan, 2024 29,857 623 645 229 8.1 12.50 Mar 12, 2025 J-GAAP
Aug - Jan, 2025 Guidance ー ー ー ー － 12.50 Sep 11, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Jul, 2025 65,260 2,367 2,553 368 12.8 25 Sep 11, 2025 J-GAAP
Jul, 2026 Guidance 68,000 1,500 1,500 1,000 34.6 25 Sep 11, 2025 J-GAAP
YoY +4.2% -36.6% -41.2% +171.7% +170.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
May - Jul, 2024 14,976 1,847 2,026 1,349 47.4 12.3 Sep 12, 2024 J-GAAP
Aug - Oct, 2024 14,596 882 888 360 12.9 6.0 Dec 11, 2024 J-GAAP
Nov - Jan, 2024 15,261 -259 -243 -131 -4.6 -1.7 Mar 12, 2025 J-GAAP
Feb - Apr, 2025 16,960 -840 -876 -1,352 -47.2 -5.0 Jun 10, 2025 J-GAAP
May - Jul, 2025 18,443 2,584 2,784 1,491 52.0 14.0 Sep 11, 2025 J-GAAP
YoY +23.2% +39.9% +37.4% +10.5% +9.6%

Related Articles